BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 32761972)

  • 41. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.
    Meadows V; Marakovits C; Ekser B; Kundu D; Zhou T; Kyritsi K; Pham L; Chen L; Kennedy L; Ceci L; Wu N; Carpino G; Zhang W; Isidan A; Meyer A; Owen T; Gaudio E; Onori P; Alpini G; Francis H
    Am J Physiol Gastrointest Liver Physiol; 2023 Jan; 324(1):G60-G77. PubMed ID: 36410025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Baihe Wuyao decoction ameliorates CCl
    Chen Y; Li R; Hu N; Yu C; Song H; Li Y; Dai Y; Guo Z; Li M; Zheng Y; Guo Z; Qi Y
    J Ethnopharmacol; 2020 Dec; 263():113227. PubMed ID: 32783983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-β/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7.
    Zhou QY; Yang HM; Liu JX; Xu N; Li J; Shen LP; Zhang YZ; Koda S; Zhang BB; Yu Q; Chen JX; Zheng KY; Yan C
    Parasit Vectors; 2021 Sep; 14(1):472. PubMed ID: 34521449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aberrant TGF-β1 signaling contributes to the development of primary biliary cirrhosis in murine model.
    Liu B; Zhang X; Zhang FC; Zong JB; Zhang W; Zhao Y
    World J Gastroenterol; 2013 Sep; 19(35):5828-36. PubMed ID: 24124327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of primary hepatic stellate cells and liver fibrosis induced by targeting TGF-β1/Smad signaling in schistosomiasis in mice.
    Huang P; Ma H; Cao Y; Zhan T; Zhang T; Wang X; Zhang Y; Xu J; Xia C
    Parasit Vectors; 2022 Dec; 15(1):456. PubMed ID: 36474240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exogenous 8-hydroxydeoxyguanosine ameliorates liver fibrosis through the inhibition of Rac1-NADPH oxidase signaling.
    Shin SK; Kim KO; Kim SH; Kwon OS; Choi CS; Jeong SH; Kim YS; Kim JH; Chung MH
    J Gastroenterol Hepatol; 2020 Jun; 35(6):1078-1087. PubMed ID: 31907970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice.
    Wu N; Meng F; Invernizzi P; Bernuzzi F; Venter J; Standeford H; Onori P; Marzioni M; Alvaro D; Franchitto A; Gaudio E; Glaser S; Alpini G
    Hepatology; 2016 Sep; 64(3):865-79. PubMed ID: 27115285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
    Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
    Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
    Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
    Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of phosphatidylinositol 3-kinase signaling pathway in radiation-induced liver injury.
    Xiao L; Zhang H; Yang X; Mahati S; Wu G; Xiaheding Y; Bao YX; Xiao H
    Kaohsiung J Med Sci; 2020 Dec; 36(12):990-997. PubMed ID: 32729224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats.
    Zhang L; Xu LM; Chen YW; Ni QW; Zhou M; Qu CY; Zhang Y
    World J Gastroenterol; 2012 Oct; 18(37):5283-8. PubMed ID: 23066324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loureirin B ameliorates cholestatic liver fibrosis via AKT/mTOR/ATG7-mediated autophagy of hepatic stellate cells.
    Cheng WY; Zeng XX; Cheng P; Zhang JX
    Eur J Pharmacol; 2024 May; 971():176552. PubMed ID: 38580181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism.
    Wilhelm A; Aldridge V; Haldar D; Naylor AJ; Weston CJ; Hedegaard D; Garg A; Fear J; Reynolds GM; Croft AP; Henderson NC; Buckley CD; Newsome PN
    Gut; 2016 Jul; 65(7):1175-85. PubMed ID: 26078290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
    Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
    Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
    [No Abstract]   [Full Text] [Related]  

  • 56. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
    Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
    Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Danhongqing formula alleviates cholestatic liver fibrosis by downregulating long non-coding RNA H19 derived from cholangiocytes and inhibiting hepatic stellate cell activation.
    Li M; Zhou Y; Zhu H; Xu LM; Ping J
    J Integr Med; 2024 Mar; 22(2):188-198. PubMed ID: 38472011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ghrelin Attenuates Liver Fibrosis through Regulation of TGF-β1 Expression and Autophagy.
    Mao Y; Zhang S; Yu F; Li H; Guo C; Fan X
    Int J Mol Sci; 2015 Sep; 16(9):21911-30. PubMed ID: 26378522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study on mechanism of curcumol against liver fibrosis based on autophagy and apoptosis of hepatic stellate cells].
    Zheng Y; Xu CL; Lu NY; Qiu FF; Zhao YJ; Chang YX; Wang JH; Zhao TJ; Yuan XL
    Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(3):730-736. PubMed ID: 35178956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling.
    Pathil A; Mueller J; Ludwig JM; Wang J; Warth A; Chamulitrat W; Stremmel W
    Br J Pharmacol; 2014 Nov; 171(22):5113-26. PubMed ID: 25041068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.